Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
12.68
-0.29 (-2.24%)
Sep 2, 2026, 3:00 PM CST

SHA:688526 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
169.96176.8543.48581.74456.07555.36
Short-Term Investments
-664.39669.19451.14810547.35
Trading Asset Securities
1,6771,542719.51745.04674.83212.95
Cash & Short-Term Investments
1,8472,3831,9321,7781,9411,316
Cash Growth
-7.86%23.36%8.68%-8.40%47.52%-39.76%
Accounts Receivable
287.68302.6354.81343.15406.52294.4
Other Receivables
4.524.324.8737.4734.9632.02
Receivables
292.2366.92359.69635.68441.48326.42
Inventory
146.13144.27125.6144.8169.4108.82
Other Current Assets
740.5832.4155.627.699.1210.42
Total Current Assets
3,0262,9272,4732,5662,5611,761
Property, Plant & Equipment
822.25877.95887.05858.9905.38904.15
Long-Term Investments
37.23907.161,0571,136799.2940.15
Goodwill
---3.313.31-
Other Intangible Assets
63.6565.7165.160.0359.9157.24
Long-Term Deferred Tax Assets
0.380.50.960.326.816.28
Long-Term Deferred Charges
0.891.121.61.18--
Other Long-Term Assets
562.539.710.9845.8835.1346.2
Total Assets
4,5134,7894,4964,6714,3913,725

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
117.23111.32178.26165.03244.27215.74
Accrued Expenses
31.0679.9287.6488.3692.7976.04
Short-Term Debt
---206.65131.618.03
Current Portion of Long-Term Debt
1.76--80.05-60.06
Current Portion of Leases
-1.611.351.060.65-
Current Income Taxes Payable
19.2646.6930.7753.9831.0946.83
Current Unearned Revenue
161.09182.37148.6157.61101.763.18
Other Current Liabilities
56.4935.5816.875.5121.7412.35
Total Current Liabilities
386.89457.5463.5758.25623.84492.24
Long-Term Debt
----140.11-
Long-Term Leases
4.835.075.555.757.12-
Long-Term Unearned Revenue
67.8269.6666.0456.6261.7247.5
Long-Term Deferred Tax Liabilities
22.5617.7917.7112.9756.8429.68
Other Long-Term Liabilities
----1.991.99
Total Liabilities
482.09550.03552.8833.59891.63571.41

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
466.13466.13466.13466.17466.21465.13
Additional Paid-In Capital
1,1301,1271,1401,1411,1351,115
Retained Earnings
2,4572,6392,3872,2041,8971,576
Treasury Stock
-17.69-17.69-34.77-0.57-1.12-1.86
Comprehensive Income & Other
-3.4224.36-17.1425.33--
Total Common Equity
4,0324,2393,9413,8363,4973,153
Minority Interest
-0.60.42.052.032.070.44
Shareholders' Equity
4,0314,2393,9433,8383,4993,154
Total Liabilities & Equity
4,5134,7894,4964,6714,3913,725

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6.596.686.9293.51279.4878.09
Net Cash (Debt)
1,8412,3771,9251,4841,6611,238
Net Cash Growth
-7.88%23.45%29.70%-10.65%34.25%-41.73%
Net Cash Per Share
3.985.114.133.193.572.67
Filing Date Shares Outstanding
459.69453.53463.92464.69466.21465.13
Total Common Shares Outstanding
459.69453.53463.92466.17466.21465.13
Working Capital
2,6392,4702,0101,8081,9371,269
Book Value Per Share
8.779.358.498.237.506.78
Tangible Book Value
3,9684,1733,8763,7723,4343,096
Tangible Book Value Per Share
8.639.208.358.097.376.66
Buildings
-374.2291.93277.02270.37237.39
Machinery
-1,069974.9954.6942.59511.38
Construction In Progress
-33.5134.5143.0517388.72